Professional Overview
Pharm Ecem Zengul is a seasoned Market Access and Pricing Manager based in Turkey, with a strong background in the pharmaceutical industry. As a current Market Access and Pricing Manager at Novo Nordisk, Ecem's key expertise areas include market access, pricing, and health economics, with a focus on the pharmaceutical and healthcare industries.
Experience Summary
Current Role
- Current Position: Market Access and Pricing Manager at Novo Nordisk (2021-06-01 to Present)
- Key Responsibilities: Developing and implementing market access and pricing strategies, collaborating with cross-functional teams to ensure successful product launches, and analyzing market trends to inform business decisions.
- Key Achievements: Although specific metrics are not available, Ecem's experience in managing market access and pricing has likely contributed to the success of product launches and revenue growth at Novo Nordisk.
- Industry Impact: As a Market Access and Pricing Manager, Ecem plays a critical role in shaping the commercial strategy for pharmaceutical products in Turkey, ultimately impacting patient access to innovative treatments.
Career Progression
- Notable Previous Roles:
- Health Economics, Market Access and Reimbursement Lead at Johnson & Johnson (2020-04-01 to 2021-06-01)
- Senior Market Access and Pricing Specialist at Merck Group (2019-05-01 to 2020-04-01)
- Market Access and Pricing Specialist at Merck Group (2016-09-01 to 2019-04-01)
- Market Access and External Affairs Project Analyst at Novartis (2015-08-01 to 2016-09-01)
- Market Access Trainee at Novartis (2015-02-01 to 2015-08-01)
- Career Trajectory and Growth: Ecem's career progression demonstrates steady growth and increasing responsibility within the pharmaceutical industry, with a focus on market access and pricing.
- Key Achievements and Contributions: While specific achievements are not detailed, Ecem's advancement through various roles underscores her competence and dedication to the field.
Academic Background
- Highest Level of Education: Master's degree in MBA from Galatasaray Üniversitesi (2019-2021)
- Relevant Specializations: Pharmacist, with a Bachelor's degree from İstanbul Üniversitesi (2010-2015)
- Notable Academic Achievements: No specific academic achievements are mentioned, but completing an MBA alongside a demanding career indicates a high level of commitment and capability.
Areas of Expertise
- Industry-Specific Skills: Market access, pricing, health economics, and reimbursement strategies within the pharmaceutical industry.
- Technical Competencies: Analytical and problem-solving skills, with the ability to interpret market data and develop strategic recommendations.
- Leadership and Management Capabilities: Ecem has demonstrated the ability to manage responsibilities and contribute to cross-functional teams, though specific leadership roles are not detailed.
Professional Impact
- Notable Projects or Initiatives: Specific projects or initiatives are not mentioned, but Ecem's work in market access and pricing has likely contributed to the launch and commercial success of various pharmaceutical products.
- Industry Contributions: By facilitating access to innovative pharmaceutical products, Ecem's work has a direct impact on patient care and public health in Turkey.
- Measurable Achievements: Although specific metrics are not provided, Ecem's contributions to product launches, pricing strategies, and market access have undoubtedly made a tangible impact on the pharmaceutical industry in Turkey.
Conclusion
Pharm Ecem Zengul's professional trajectory is marked by steady advancement and increasing responsibility within the pharmaceutical industry, with a specialized focus on market access and pricing. Currently, as a Market Access and Pricing Manager at Novo Nordisk, Ecem continues to leverage her expertise to drive commercial strategy and ensure patient access to innovative treatments. With a strong educational background and a history of professional growth, Ecem presents a compelling value proposition as a dedicated, knowledgeable, and strategic leader in the pharmaceutical sector.
